VERA
Vera Therapeutics, Inc.
+2.01 (+6.33%)33.78USD1.6M成交股數2.4B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 60.1M | 86.0M | 56.5M | 58.2M | 41.3M | 33.3M | 40.3M | 29.3M | 23.2M | 16.1M | 16.2M | 25.1M |
| 銷售管理費用 | 52.4M | 39.1M | 27.5M | 21.9M | 15.9M | 15.6M | 9.5M | 8.0M | 7.9M | 5.7M | 5.7M | 6.2M |
| 營業利益 | −112M+97% | −125M+156% | −83.9M+69% | −80.1M+115% | −57.2M+84% | −48.9M+125% | −49.8M+127% | −37.3M+19% | −31.1M | −21.8M | −22.0M | −31.3M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −109M+112% | −121M+179% | −80.3M+72% | −76.5M+127% | −51.7M+82% | −43.4M+116% | −46.6M+131% | −33.7M+12% | −28.4M | −20.1M | −20.2M | −30.1M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -1.52+88% | -1.69+135% | -1.26+48% | -1.20+94% | -0.81+45% | -0.72+60% | -0.85+85% | -0.62-23% | -0.56 | -0.45 | -0.46 | -0.80 |
| 稀釋股數 | 71.8M | 71.5M | 63.8M | 63.8M | 63.7M | 55.3M | 54.9M | 54.7M | 51.0M | 44.4M | 44.3M | 37.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 48.9M | 114M | 57.8M | 49.1M | 55.1M | 92.6M | 27.3M | 25.1M | 69.1M | 27.4M | 33.9M | 137M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 533M | 622M | 518M | 579M | 610M | 656M | 369M | 397M | 419M | 176M | 195M | 210M |
| 有息負債 | 75.2M | 75.0M | 74.6M | 74.5M | 50.9M | 50.7M | 50.5M | 50.3M | 50.1M | 25.0M | 25.0M | 24.9M |
| 總負債 | 125M | 122M | 119M | 110M | 75.2M | 78.5M | 79.5M | 69.4M | 65.8M | 51.9M | 54.7M | 51.9M |
| 股東權益 | 408M | 500M | 399M | 468M | 535M | 577M | 289M | 328M | 354M | 124M | 141M | 158M |
| 負債比 | 23.5% | 19.6% | 22.9% | 19.1% | 12.3% | 12.0% | 21.6% | 17.5% | 15.7% | 29.6% | 28.0% | 24.8% |
| 淨現金(現金 − 有息負債) | −26.4M | 39.3M | −16.9M | −25.3M | 4.2M | 42.0M | −23.2M | −25.2M | 19.0M | 2.4M | 8.9M | 112M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −107M | – | – | −54.4M+61% | – | – | – | −33.8M | – | – | −26.3M |
| 資本支出 | – | 23K | – | – | 187K | – | – | – | 0.00 | – | – | 0.00 |
| 自由現金流 | – | −107M | – | – | −54.6M+61% | – | – | – | −33.8M | – | – | −26.3M |
| 折舊攤銷 | – | 140K | – | – | 85K | – | – | – | 11K | – | – | −506K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −300M | –% | -4.66 | −242M |
| FY2024 | – | – | −152M | –% | -2.75 | −136M |
| FY2023 | – | – | −96.0M | –% | -2.25 | −92.2M |
| FY2022 | – | – | −89.1M | –% | -3.35 | −67.7M |
| FY2021 | – | – | −32.6M | –% | -2.43 | −23.7M |
| FY2020 | – | – | −53.4M | –% | -166.93 | −34.9M |